- ISIN
- US3795772082
- CUSIP
- 379577208
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Aug 3, 2012
Highlights
- Market Cap
- $10.94B
- Enterprise Value
- $10.51B
- EPS (TTM)
- $4.29
- PE Ratio
- 18.47
- PEG Ratio
- 0.20
- Total Revenue (TTM)
- $3.10B
- Gross Profit (TTM)
- $1.58B
- EBITDA (TTM)
- $803.34M
- Year Range
- $51.79 - $101.40
- Target Price
- $110.67
- ROA (TTM)
- 10.79%
- ROE (TTM)
- 12.40%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GMED Performance Chart
Globus Medical, Inc. (GMED) is down 9.3% since the beginning of the year. At $79 per share, GMED is trading 21.9% below its 52-week high of $101. Investors who bought $1,000 worth of GMED shares 5 years ago would now be looking at an investment worth $1,066.
Loading charts...
Returns By Period
Globus Medical, Inc. (GMED) has returned -9.30% so far this year and 36.84% over the past 12 months. Over the last ten years, GMED has returned 12.75% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Globus Medical, Inc.
- 1D
- -0.05%
- 1M
- -6.63%
- YTD
- -9.30%
- 6M
- -11.38%
- 1Y
- 36.84%
- 3Y*
- 10.67%
- 5Y*
- 1.28%
- 10Y*
- 12.75%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
GMED Monthly Returns History
Based on dividend-adjusted daily data since Aug 3, 2012, GMED's average daily return is +0.08%, while the average monthly return is +1.58%. At this rate, an investment would double in approximately 3.7 years.
Historically, 58% of months were positive and 42% were negative. The best month was Nov 2025 with a return of +50.8%, while the worst month was Feb 2023 at -22.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.
On a daily basis, GMED closed higher 51% of trading days. The best single day was Nov 7, 2025 with a return of +35.9%, while the worst single day was May 9, 2025 at -23.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.86% | 5.27% | -9.74% | 4.67% | -9.20% | -3.29% | -9.30% | ||||||
| 2025 | 12.10% | -13.37% | -8.86% | -1.95% | -17.54% | -0.27% | -10.83% | 16.42% | -6.53% | 5.45% | 50.75% | -4.10% | 5.56% |
| 2024 | -0.94% | 2.27% | -0.65% | -7.18% | 34.79% | 2.06% | 5.07% | 1.03% | -1.60% | 2.80% | 16.41% | -3.39% | 55.21% |
| 2023 | 1.66% | -22.73% | -2.91% | 2.65% | -6.90% | 9.99% | 1.23% | -10.24% | -8.23% | -7.94% | -1.73% | 18.63% | -28.25% |
| 2022 | -7.58% | 5.38% | 4.92% | -10.25% | 0.57% | -15.71% | 4.54% | 0.85% | 0.64% | 12.47% | 10.28% | 0.51% | 2.87% |
| 2021 | -5.41% | 1.31% | -1.33% | 16.38% | 0.40% | 7.59% | 7.27% | -1.89% | -6.10% | 0.72% | -18.85% | 15.30% | 10.70% |
Benchmark Metrics
Globus Medical, Inc. has an annualized alpha of 7.15%, beta of 0.89, and R2 of 0.18 versus S&P 500 Index. Calculated based on daily prices since August 03, 2012.
- This stock captured 113.00% of S&P 500 Index gains and 111.57% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.18 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.15%
- Beta
- 0.89
- R²
- 0.18
- Upside Capture
- 113.00%
- Downside Capture
- 111.57%
Return for Risk
Risk / Return Rank
GMED ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMED | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.27 | ||
| Sortino ratioReturn per unit of downside risk | -0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.37 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | 2.78 | -1.11 |
| Martin ratioReturn relative to average drawdown | 4.30 | 12.44 | -8.14 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Globus Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Globus Medical, Inc. was 47.91%, occurring on Nov 13, 2023. Recovery took 258 trading sessions.
The current Globus Medical, Inc. drawdown is 18.21%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -47.91%Nov 2023 | 2y 2mo | 1y 9d | 3y 2moSep 2021 - Nov 2024 |
2012 bear market2012 | -44.69%Dec 2012 | 2mo 26d | 10mo 7d | 1y 28dOct 2012 - Oct 2013 |
2025 bear market2025 | -44.40%Jul 2025 | 5mo 29d | 5mo 21d | 11mo 20dJan 2025 - Jan 2026 |
COVID crash2020 | -41.08%Mar 2020 | 2mo 27d | 8mo 13d | 11mo 10dDec 2019 - Nov 2020 |
2019 bear market2019 | -33.70%Jan 2019 | 1mo 25d | 11mo 13d | 1y 1moNov 2018 - Dec 2019 |
Drawdown Indicators
| GMED | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.91% | -56.78% | +8.87% |
Max Drawdown (1Y)Largest decline over 1 year | -22.10% | -9.10% | -13.00% |
Max Drawdown (3Y)Largest decline over 3 years | -44.40% | -18.90% | -25.50% |
Max Drawdown (5Y)Largest decline over 5 years | -47.91% | -25.43% | -22.48% |
Max Drawdown (10Y)Largest decline over 10 years | -47.91% | -33.92% | -13.99% |
Current DrawdownCurrent decline from peak | -18.21% | -1.80% | -16.41% |
Average DrawdownAverage peak-to-trough decline | -15.33% | -10.71% | -4.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.58% | 2.03% | +6.55% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Globus Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Globus Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for GMED, comparing it with other companies in the Medical Devices industry. Currently, GMED has a P/E ratio of 18.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for GMED compared to other companies in the Medical Devices industry. GMED currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GMED relative to other companies in the Medical Devices industry. Currently, GMED has a P/S ratio of 3.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for GMED in comparison with other companies in the Medical Devices industry. Currently, GMED has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with GMED
Add Globus Medical, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GMED